HEMOLYSIN OF MYCOPLASMA PNEUMONIAE

Insights

Mycoplasma pneumoniae produces a heat-labile hemolysin that lyses guinea pig red blood cells. This substance is continuously released, has low molecular weight, and is likely nonproteinaceous.

Area of Science:

  • Microbiology
  • Bacteriology

Background:

  • Mycoplasma pneumoniae is a pathogen known to cause respiratory infections.
  • Hemolysin production by microorganisms can contribute to virulence and pathogenesis.

Purpose of the Study:

  • To investigate the characteristics of the hemolysin produced by Mycoplasma pneumoniae.
  • To determine the factors influencing hemolysin production and its properties.

Main Methods:

  • Culturing Mycoplasma pneumoniae and M. laidlawii on agar plates.
  • Observing hemolysis of guinea pig erythrocytes.
  • Manipulating culture conditions (colony density, medium composition, oxygen tension).
  • Assessing hemolysin production in non-viable or aged colonies.
  • Utilizing micromanipulation and dialysis to characterize the hemolysin.

Main Results:

  • Discrete colonies of Mycoplasma pneumoniae and M. laidlawii produced complete (beta) hemolysis of guinea pig erythrocytes.
  • Hemolysin production was inhibited by colony crowding, omission of yeast extract, and reduced oxygen tension.
  • Non-viable colonies (UV-irradiated, heat-treated, aged) did not produce hemolysin.
  • Hemolysin was continuously released, passed through a dialysis membrane, and was heat-labile.

Conclusions:

  • The hemolysin produced by Mycoplasma pneumoniae is a labile substance of low molecular weight, likely nonprotein in nature.
  • Hemolysin production is dependent on viable, actively growing Mycoplasma colonies.
  • These findings provide insights into the biochemical properties and release mechanism of Mycoplasma hemolysin.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Phylum Tenericutes01:24

Bacterial Phylum Tenericutes

The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...